The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Much Growth In Market Value Is Expected For The Hospital Acquired Infections Testing Kits Market Between 2026 And 2030?
The market size for hospital acquired infections testing kits has seen substantial growth recently. This market is projected to expand from $4.79 billion in 2025 to $5.19 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.5%. The expansion observed in the historic period is due to increasing hospital infection surveillance, the rising prevalence of antibiotic-resistant pathogens, the expansion of clinical microbiology labs, the implementation of infection control protocols, and the availability of molecular diagnostic tools.
The hospital acquired infections testing kits market size is projected to experience robust expansion in the coming years. This market is anticipated to reach $7.2 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.5%. Factors driving this growth during the forecast period include a heightened emphasis on prompt infection identification, increased capital allocation for hospital safety infrastructure, wider adoption of rapid testing methods, an escalating need for automated diagnostic processes, and progress in molecular diagnostics technology. Key trends observed within the forecast timeframe involve the growing uptake of rapid diagnostic test kits, increased application of molecular testing for HAIs, expanding incorporation of automated diagnostic instruments, the broadening scope of point-of-care infection testing, and a stronger focus on detecting multiple pathogens.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2469&type=smp
What Significant Factors Are Influencing The Hospital Acquired Infections Testing Kits Market Expansion?
The increasing number of healthcare settings is anticipated to drive the expansion of the hospital-acquired infections testing kits market in the future. Within a healthcare setting, a wide array of facilities and services are available, including acute care hospitals, urgent care centers, rehabilitation facilities, nursing homes, and long-term care facilities, which together provide comprehensive healthcare solutions. Hospital-acquired infections testing kits are essential tools for detecting and preventing nosocomial infections, thereby improving patient safety in healthcare facilities. For instance, in May 2023, the American Hospital Association, a US-based healthcare industry trade group, reported a significant increase in the total number of hospitals in the U.S. region, rising from 6,093 in 2022 to 60,129 in 2023. Additionally, community hospital admissions also grew, going from 31,393,318 in 2022 to 31,967,073 in 2023. Hence, the rising prevalence of healthcare settings is a key factor propelling the hospital-acquired infections testing kits market.
Which Segment Types Are Examined In The Hospital Acquired Infections Testing Kits Market Segment Study?
The hospital acquired infections testing kits market covered in this report is segmented –
1) By Product: Consumables And Reagents, Instruments
2) By Test Type: Pneumoia Infection, Urinary Track Infection, Blood Stream Associated Infection, Surgical Site Infection, MRSA infection, Others
3) By Pathogen Type: Viral, Bacterial, Fungal
4) By Application: Drug Resistance Testing, Disease Testing
Subsegments:
1) By Consumables and Reagents: Culture Media (Used for isolating and identifying pathogens), Reagents For Molecular Testing (Includes PCR reagents and kits for detecting specific pathogens), Test Kits (Rapid tests and other kits designed for various infections), Other Consumables (Includes swabs, sample collection devices, and preservation solutions)
2) By Instruments: Automated Analyzers (Equipment used for blood culture analysis and identification of pathogens), Molecular Diagnostic Instruments (Machines used for PCR and other molecular testing methods), Microscopes (Used for the identification of pathogens in samples), Incubators And Growth Chambers (For culturing samples under controlled conditions)
What Trends Are Affecting The Direction Of The Hospital Acquired Infections Testing Kits Market?
Major companies in the hospital-acquired infections (HAI) testing kits market are focusing on developing advanced point-of-care antimicrobial susceptibility testing (AST) solutions to enable rapid diagnosis, guide targeted therapy, and combat antimicrobial resistance (AMR). Point-of-care AST leverages proprietary microfluidic technology to quickly detect bacterial presence and assess antibiotic effectiveness directly from patient urine samples, reducing diagnostic delays and improving treatment decisions. For instance, in June 2023, Sysmex Corporation, a Japan-based diagnostics company, introduced the world’s first point-of-care testing system in Europe capable of performing antimicrobial susceptibility testing in just 30 minutes. Using a microfluidic-based AST approach for patients suspected of urinary tract infections, the system significantly reduces turnaround time and supports antimicrobial stewardship in primary care settings by enabling timely and informed antibiotic use, thereby contributing to global efforts to curb AMR.
Which Players Are Part Of The Competitive Landscape Of The Hospital Acquired Infections Testing Kits Market?
Major companies operating in the hospital acquired infections testing kits market are Becton Dickinson and Company, Abbott Laboratories, Cepheid, F. Hoffmann-La Roche Ltd, STERIS plc, QIAGEN, Meridian Bioscience Inc., BioMérieux SA, GE Healthcare, Seegene, SD Biosensor, Fujirebio, Sysmex Corporation, Getein Biotech, Hangzhou Biotest Biotech, AmonMed Biotechnology, Beijing Tigsun Diagnostics, Hunan Lituo Biotechnology, ImmunoScience, Vivacheck Lab
Get The Full Hospital Acquired Infections Testing Kits Market Report:
Which Region Holds The Highest Market Share In The Hospital Acquired Infections Testing Kits Market?
North America was the largest region in the hospital-acquired infections testing kits market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hospital acquired infections testing kits market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Hospital Acquired Infections Testing Kits Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/customise?id=2469&type=smp
Browse Through More Reports Similar to the Global Hospital Acquired Infections Testing Kits Market 2026, By The Business Research Company
Viral Diagnostic Test Kits Market Report 2026
https://www.thebusinessresearchcompany.com/report/viral-diagnostic-test-kits-global-market-report
Infection Control Supplies Market Report 2026
https://www.thebusinessresearchcompany.com/report/infection-control-supplies-global-market-report
Hospital Acquired Infection Control Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model